About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Los Angeles | 43 Studies

Clinical Trials Alzheimer's DiseaseLos Angeles

Alzheimer's Disease Clinical Trials in Los Angeles

Find 43 clinical trials for alzheimer's disease near Los Angeles, California. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 43 trials

CompletedNicotinamide as an Early Alzheimer's Disease TreatmentThe purpose of this research study is to test whether nicotinamide, also known as vitamin B3 or niacinamide, taken in high doses, can reduce phosphorylation of tau (the protein…NCT03061474·Irvine, California and 1 other TerminatedProgress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboTo test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.NCT01900665·Phoenix, Arizona and 197 others

Alzheimer's Disease Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)The primary specific aim of this clinical trial is to determine whether treatment with rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in…NCT00004845·Phoenix, Arizona and 39 others

CompletedMemory Impairment Study (Mild Cognitive Impairment Study)The National Institute on Aging (NIA) is launching a nationwide treatment study targeting individuals with mild cognitive impairment (MCI), a condition characterized by a memory…NCT00000173·Phoenix, Arizona and 71 others

CompletedRandomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the potential benefits of CERE-110 in the treatment of Alzheimer's disease.NCT00876863·Birmingham, Alabama and 9 others

Active not recruitingA Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseThis study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with…NCT03887455·Phoenix, Arizona and 246 others

Terminated221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseThe primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical…NCT02477800·Phoenix, Arizona and 180 others

Active not recruitingA Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD) over up to 332 weeks.NCT05026866·Birmingham, Alabama and 215 others

CompletedHealthy Aging and Memory StudyThis project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in Alzheimer's Disease (AD) primary prevention…NCT00034567·Birmingham, Alabama and 38 others

CompletedADNI: Alzheimer's Disease Neuroimaging InitiativeThe purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early…NCT00106899·Birmingham, Alabama and 58 others

RecruitingA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseThis is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD…NCT07094516·Phoenix, Arizona and 73 others

Active not recruitingEscitalopram for Agitation in Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of escitalopram for agitation in Alzheimer's dementia.NCT03108846·Sun City, Arizona and 28 others

Active not recruitingLongitudinal Early-onset Alzheimer's Disease Study ProtocolThe Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals…NCT03507257·Sun City, Arizona and 22 others

CompletedImpact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 YearConstituents of grapes have been studied for their antioxidant, anti-inflammatory, and anticarcinogenic properties.NCT03361410·Los Angeles, California

Enrolling by invitationThe Diabetes Prevention Program Outcomes Study AD/ADRD ProjectThe DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2…NCT05704309·Phoenix, Arizona and 26 others

CompletedA Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's DiseaseAZD0530 is an inhibitor of Src and Abl family kinases1. It has been developed as treatment for malignancies because these kinases play a role in tumor invasion and proliferation.NCT02167256·Phoenix, Arizona and 21 others

CompletedPrevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium and Vitamin E Cancer Prevention Trial…NCT00040378·Birmingham, Alabama and 90 others

Enrolling by invitationAlzheimer's Disease Neuroimaging Initiative 4The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design…NCT05617014·Birmingham, Alabama and 64 others

TerminatedA Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseThe primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's Disease Rating Scale…NCT04619420·Birmingham, Alabama and 121 others

CompletedCATIE-Alzheimer's Disease TrialThe CATIE Alzheimer's Disease Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project.NCT00015548·Tuscaloosa, Alabama and 33 others

Page 1 of 3Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia